Search Our Website:

In two separate decisions involving the same parties, the Federal Circuit affirmed the PTAB’s determination that claims challenged in a CBM proceeding are eligible for CBM review and are unpatentable under 35 U.S.C. § 101. A patent is eligible for CBM review if it “claims a method or corresponding apparatus for performing data processing or other operations used in the practice, administration, or management of a financial product or service, except that the term does not include patents for technological inventions." In its opinions, the Court elaborated on the “technological invention” exception to CBM review.

Read the full article.